Ann M. Buchanan

571 total citations
29 papers, 278 citations indexed

About

Ann M. Buchanan is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ann M. Buchanan has authored 29 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Ann M. Buchanan's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). Ann M. Buchanan is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). Ann M. Buchanan collaborates with scholars based in United States, United Kingdom and Tanzania. Ann M. Buchanan's co-authors include Coleen K. Cunningham, Scott Sherman, John A. Crump, John Bartlett, Levina Msuya, Boniface Njau, Jean Gratz, Florida Muro, Anne B. Morrissey and Galina Florova and has published in prestigious journals such as PLoS ONE, Clinical Microbiology Reviews and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ann M. Buchanan

27 papers receiving 274 citations

Peers

Ann M. Buchanan
Paddy McMaster United Kingdom
Abel Makubi Tanzania
KHF Wong United Kingdom
Melak Aynalem Ethiopia
F Mulcahy Ireland
Ann M. Buchanan
Citations per year, relative to Ann M. Buchanan Ann M. Buchanan (= 1×) peers Benjamin Momo Kadia

Countries citing papers authored by Ann M. Buchanan

Since Specialization
Citations

This map shows the geographic impact of Ann M. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann M. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann M. Buchanan more than expected).

Fields of papers citing papers by Ann M. Buchanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann M. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann M. Buchanan. The network helps show where Ann M. Buchanan may publish in the future.

Co-authorship network of co-authors of Ann M. Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Ann M. Buchanan. A scholar is included among the top collaborators of Ann M. Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann M. Buchanan. Ann M. Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puthanakit, Thanyawee, Linda Aurpibul, S.Y. Amy Cheung, et al.. (2025). Efficacy and Safety of the Two-Drug Regimen Dolutegravir–Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-Label, Phase 3b Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(2). 202–210.
2.
Dirajlal‐Fargo, Sahera, Jennifer Jao, Jorge Pinto, et al.. (2025). Cardiometabolic Health Burden in Pediatric HIV: Unmet Need in the Contemporary Antiretroviral Therapy Era. Cureus. 17(6). e85329–e85329. 1 indexed citations
3.
Chandasana, Hardik, Ann M. Buchanan, Michael J. McKenna, et al.. (2024). A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1. The Journal of Clinical Pharmacology. 65(1). 18–27.
4.
Buchanan, Ann M., Adrie Bekker, Hardik Chandasana, et al.. (2024). Advancing research and development of anti-infectives for children with a focus on antiretroviral therapy: A clinical development perspective. International Journal of Antimicrobial Agents. 64(4). 107306–107306. 1 indexed citations
5.
Chandasana, Hardik, et al.. (2023). Effect of Food on the Pediatric Dispersible Tablet Formulations of TRIUMEQ and DOVATO in Healthy Adult Participants. Pharmaceutics. 15(5). 1470–1470. 1 indexed citations
6.
Dow, Dorothy E., Werner Schimana, Balthazar Nyombi, et al.. (2017). HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania. AIDS Research and Human Retroviruses. 33(11). 1107–1113. 6 indexed citations
7.
Buchanan, Ann M., et al.. (2017). Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low‐ and High‐Mineral‐Content Water on the Tablet in Healthy Adults. Clinical Pharmacology in Drug Development. 6(6). 577–583. 7 indexed citations
8.
Ross, Lisa, Ivy Song, Niki Arya, et al.. (2016). No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects. BMC Infectious Diseases. 16(1). 347–347. 5 indexed citations
9.
Komissarov, Andrey A., Galina Florova, Ali Azghani, et al.. (2016). Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models. American Journal of Physiology-Lung Cellular and Molecular Physiology. 311(2). L389–L399. 21 indexed citations
10.
Komissarov, Andrey A., Galina Florova, Ali Azghani, et al.. (2015). The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits. American Journal of Physiology-Lung Cellular and Molecular Physiology. 309(6). L562–L572. 11 indexed citations
11.
Buchanan, Ann M., et al.. (2015). Establishment of biochemistry reference values for healthy Tanzanian infants, children and adolescents in Kilimanjaro Region. Tropical Medicine & International Health. 20(11). 1569–1577. 14 indexed citations
12.
Buchanan, Ann M., Dorothy E. Dow, Charles Massambu, et al.. (2014). Progress in the Prevention of Mother to Child Transmission of HIV in Three Regions of Tanzania: A Retrospective Analysis. PLoS ONE. 9(2). e88679–e88679. 17 indexed citations
13.
Cunningham, Coleen K., et al.. (2013). Prevalence of Mycobacteremia Among HIV-infected Infants and Children in Northern Tanzania. The Pediatric Infectious Disease Journal. 32(7). 754–756. 5 indexed citations
14.
Ramadhani, Habib O., Levina Msuya, Boniface Njau, et al.. (2012). Predicting mortality for paediatric inpatients where malaria is uncommon. Archives of Disease in Childhood. 97(10). 889–894. 10 indexed citations
15.
Buchanan, Ann M., Behzad Nadjm, Ben Amos, et al.. (2012). Utility of rapid antibody tests to exclude HIV-1 infection among infants and children aged <18 months in a low-resource setting. Journal of Clinical Virology. 55(3). 244–249. 5 indexed citations
16.
Buchanan, Ann M., Florida Muro, Jean Gratz, et al.. (2010). Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region. Tropical Medicine & International Health. 15(9). no–no. 68 indexed citations
17.
Buchanan, Ann M. & Coleen K. Cunningham. (2009). Advances and Failures in Preventing Perinatal Human Immunodeficiency Virus Infection. Clinical Microbiology Reviews. 22(3). 493–507. 14 indexed citations
18.
Sherman, Scott & Ann M. Buchanan. (2004). Gradenigo syndrome: A case report and review of a rare complication of otitis media. Journal of Emergency Medicine. 27(3). 253–256. 24 indexed citations
19.
Buchanan, Ann M.. (2000). The ethics of mandatory versus voluntary HIV testing of pregnant women. Current Surgery. 57(2). 166–168. 1 indexed citations
20.
Buchanan, Ann M. & Robert S. Tan. (1997). Congestive heart failure in elderly patients. Postgraduate Medicine. 102(4). 207–215. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026